Investigation of β-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea

Journal of Microbiology and Biotechnology

Volumn 17, Issue 10, 2007, Pages 1733-1737

  Sohn, Eui Suk ^a,b,c   Yoo, Jeong Sik ^a   Lee, Jeom Kyu ^a   Lee, Kyeong Min ^a   Chung, Gyung Tae ^a   Shin, Eun Shim ^a   Han, Sun Young ^a   Lee, Sang Hee ^b   Kim, Joon ^c   Lee, Yeong Seon ^a  

^a Korea National Institute of Health   (South Korea)

^b Myong Ji University   (South Korea)

^c Korea University   (South Korea)

Author keywords

Multidrug resistance; OXA 10; PER 1; Pseudomonas aeruginosa; VIM 2

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; EDETIC ACID; GENTAMICIN; IMIPENEM; MONOBACTAM; PENICILLIN G; PIPERACILLIN; QUINOLONE DERIVATIVE; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENE SEQUENCE; KOREA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; TERTIARY HEALTH CARE;

BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; KOREA; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA;

PSEUDOMONAS AERUGINOSA;

EID: 36048992085     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Baddour, L. M., D. V Hicks, M. M. Tayidi, S. K. Roberts, E. Walker, R. J. Smith, D. S. Sweitzer, J. A. Herrington, and B. G Painter. 1995. Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospital. Microb. Drug Resist. 1: 219-222.
2. Chastre, J. and J. L. Trouillet. 2000. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin. Respir. Infect. 15: 287-298.
3. Cho, B. G, C. H. Kim, B. K. Lee, and S. H. Cho. 2005. Comparison of antibiotic resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733.
4. Clinical and Laboratory Standards Institute (CLSI). 2006. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A6, 7th Ed. Clinical and Laboratory Standards Institute, Wayne, PA, U.S.A.
5. Falagas, M. E., P. K. Koletsi, and I. A. Bliziotis. 2006. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 55: 1619-1629.
6. Ferrara, A. M. 2006. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. Int. J. Antimicrob. Agents 27: 193-195.
7. Gales, A. C., R. N. Jones, J. Turnidge, R. Rennie, and R. Ramphal. 2001. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32: S146-S155.
8. Hsu, D. I., M. P. Okamoto, R. Murthy, and A. Wong-Beringer. 2005. Fluoroquinolone-resistant Pseudomonas aeruginosa: Risk factors for acquisition and impact on outcomes. J. Antimicrob. Chemother. 55: 535-541.
9. IMP-1 in clinical isolate multiresistant Acinetobacter baumannii from Korea J. Microbiol. Biotechnol. 16: 1377-1383.
10. Kiska, D. L. and P. H. Gilligan. 1999. Pseudomonas, pp. 517-525. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (eds.), Manual of Clinical Microbiology, 7th Ed. American Society for Microbiology, Washington, DC, U.S.A.
11. Lee, K., Y Chong, H. B. Shin, Y. A. Kim, D. Young, and J. H. Yum. 2000. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7: 88-102.
12. Lee, S., Y. J. Park, M. Kim, H. K. Lee, K. Han, C. S. Kang, and M. W. Kang. 2005. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J. Antimicrob. Chemother. 56: 122-127.
13. CMY-11, an AmpC-type plasmid-mediated β-lactamase gene in a Korean clinical isolate of Escherichia coli. J. Antimicrob. Chemother. 49: 269-273.
14. Lee, S. H., J. Y Kim, S. K. Lee, W. Jin, and K. J. Lee. 2000. Discriminatory detection of extended-spectrum β-lactamases by restriction fragment length dimorphism-polymerase chain reaction. Lett. Appl. Microbiol. 31: 307-312.
15. Leibovici, L., I. Shraga, M. Drucker, H. Konigsberger, Z. Samra, and S. D. Pitlik. 1998. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J. Intern. Med. 244: 379-386.
16. Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa. Our worst nightmare? Clin. Infect. Dis. 34: 634-640.
17. Lodise, T. P., C. D. Miller, J. Graves, J. P. Furuno, J. C. McGregor, B. Lomaestro, E. Graffunder, and L. A. McNutt. 2007. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob. Agents Chemother. 51: 417-422.
18. Obritsch, M. D., D. N. Fish, R. MacLaren, and R. Jung. 2004. National surveillance of antimicrobial resistance in Pseudomonos aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob. Agents Chemother. 48: 4606-4610.
19. Partridge, S. and R. M. Hall. 2003. In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob. Agents Chemother. 47: 342-349.
20. PER-1 gene in Gram-negative bacteria. Antimicrob. Agents Chemother. 49: 1708-1713.
21. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44: 891-897.
22. Sekiguchi, J. I., T. Asagi, T. Miyoshi-Akiyama, A. Kasai, Y. Mizuguchi, M. Araake, T. Fujino, H. Kikuchi, S. Sasaki, H. Watari, T. Kojima, H. Miki, K. Kanemitsu, H. Kunishima, Y. Kikuchi, M. Kaku, H. Yoshikwa, T. Kuratsuji, and T. Kirikae. 2007. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J. Clin. Microbiol. 45: 979-989.
23. Shin, H.-J., S.-K. Lee, J. J. Choi, S. Koh, J.-H. Lee, S.-J. Kim, and S. T. Kwon. 2005. Cloning, expression, and characterization of a family B-type DNA polymerase from the hyperthermophilic crenarchaeon Pyrobaculum arsenaticum and its application to PCR. J. Microbiol. Biotechnol. 15: 1359-1367.
24. Trick, W. E., C. M. Kioski, K. M. Howard, G. D. Cage, J. I. Tokars, B. M. Yen, and W. R. Jarvis. 2000. Outbreak of Pseudomonas aeruginosa ventriculitis among patients in a neurosurgical intensive care unit. Infect. Control Hosp. Epidemiol. 21: 204-208.
25. Vahaboglu, H., R. Ozturk, H. Akbal, S. Saribas, O. Tansel, and F. Coskunkan. 1998. Practical approach for detection and identification of OXA-10-derived ceflazidime hydrolyzing extended-spectrum beta-lactamases. J. Clin. Microbiol. 36: 827-829.
26. Weldhagen, G. F., B. Kim, C.-H. Cho, and S. H. Lee. 2006. Definitive nomenclature of GES/IBC-type extended-spectrum β-lactamases. J. Microbiol. Biotechnol. 16: 1837-1840.